48. H. Li, Q. Yao, F. Xu, Y. Li, D. Kim, J. Chung, G. Baek, X. Wu, P.F. Hillman, E.Y. Lee, H. Ge,

J. Fan, J. Wang, S.-J. Nam, X. Peng & J. Yoon (2020) An activatable aiegen probe for

high‐fidelity monitoring of overexpressed tumor enzyme activity and its application to sur­

gical tumor excision. Angewandte Chemie, 132, 10272–10281.

49. J.P. Kim, Z. Xie, M. Creer, Z. Liu & J. Yang (2017) Citrate-based fluorescent materials for low-

cost chloride sensing in the diagnosis of cystic fibrosis. Chemical Science, 8, 550–558.

50. V. Kumar, D.K. Dwivedi & N.R. Jagannathan (2014) High‐resolution NMR spectroscopy of

human body fluids and tissues in relation to prostate cancer. NMR in Biomedicine, 27, 80–89.

51. R. Schicho, R. Shaykhutdinov, J. Ngo, A. Nazyrova, C. Schneider, R. Panaccione, G.G. Kaplan,

H.J. Vogel & M. Storr (2012) Quantitative metabolomic profiling of serum, plasma, and urine

by 1H NMR spectroscopy discriminates between patients with inflammatory bowel disease

and healthy individuals. Journal of Proteome Research, 11, 3344–3357.

52. P. Dutta, M.R. Perez, J. Lee, Y. Kang, M. Pratt, T.C. Salzillo, J. Weygand, N.M. Zacharias,

S.T. Gammon, E.J. Koay, M. Kim, F. McAllister, S. Sen, A. Maitra, D. Piwnica-Worms,

J.B. Fleming & P.K. Bhattacharya (2019) Combining hyperpolarized real-time metabolic

imaging and NMR spectroscopy to identify metabolic biomarkers in pancreatic cancer.

Journal of Proteome Research, 18, 2826–2834.

53. B.K. Gale, A.R. Jafek, C.J. Lambert, B.L. Goenner, H. Moghimifam, U.C. Nze & S.K.

Kamarapu (2018) A review of current methods in microfluidic device fabrication and future

commercialization prospects. Inventions, 3, 60.

54. V. Soum, S. Park, A.I. Brilian, O.S. Kwon & K. Shin (2019) Programmable paper-based

microfluidic devices for biomarker detections. Micromachines, 10, 516.

55. T. Osaki, Y. Shin, V. Sivathanu, M. Campisi & R.D. Kamm (2018) In vitro microfluidic

models for neurodegenerative disorders. Advanced Healthcare Materials, 7, 1700489.

56. A.A. Dawoud, T. Kawaguchi, Y. Markushin, M.D. Porter & R. Jankowiak (2006) Separation

of catecholamines and dopamine-derived DNA adduct using a microfluidic device with

electrochemical detection. Sensors and Actuators B: Chemical, 120, 42–50.

57. M.H. Lee, D. O’Hare, Y.L. Chen, Y.C. Chang, C.H. Yang, B.D. Liu & H.Y. Lin (2014)

Molecularly imprinted electrochemical sensing of urinary melatonin in a microfluidic system.

Biomicrofluidics, 8, 054115.

58. X. Yang, R. Jiao, L. Yang, L.P. Wu, Y.R. Li & J. Wang (2011) New-generation high-throughput

technologies based’omics’ research strategy in human disease. Yi Chuan Hereditas, 33, 829–846.

59. S. Oh, Y. Jo, S. Jung, S. Yoon & K.H. Yoo (2020) From genome sequencing to the discovery of

potential biomarkers in liver disease. BMB Reports, 53, 299.

60. A. Vanderstichele, P. Busschaert, S. Olbrecht, D. Lambrechts & I. Vergote (2017) Genomic

signatures as predictive biomarkers of homologous recombination deficiency in ovarian

cancer. European Journal of Cancer, 86, 5–14.

61. P. Song, N.D. Hershey, O.S. Mabrouk, T.R. Slaney & R.T. Kennedy (2012) Mass spectrometry

“sensor” for in vivo acetylcholine monitoring. Analytical Chemistry, 84, 4659–4664.

138

Bioelectronics